These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11826018)

  • 1. The null oncogene hypothesis and protection from cancer.
    Davenport MP; Ward RL; Hawkins NJ
    J Med Genet; 2002 Jan; 39(1):12-4. PubMed ID: 11826018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncogenes, antioncogenes and carcinogenesis].
    Kopnin BP
    Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of carcinogenesis in familial tumors.
    Tamura K; Utsunomiya J; Iwama T; Furuyama J; Takagawa T; Takeda N; Fukuda Y; Matsumoto T; Nishigami T; Kusuhara K; Sagayama K; Nakagawa K; Yamamura T
    Int J Clin Oncol; 2004 Aug; 9(4):232-45. PubMed ID: 15375699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological evidence of differential oncogene activation-tumor suppressor gene inactivation features in 10 human neoplasias, as revealed by sequential regression analysis of world cancer incidence data.
    Kodama M; Murakami M; Kodama T
    Anticancer Res; 1997; 17(5B):3809-16. PubMed ID: 9427785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the oncogene activation profiles and the tumor suppressor gene inactivation profiles in 19 human neoplasias - a regression analysis study of the intercancer linkage with the world cancer incidence data.
    Kodama M; Murakami M; Kodama T
    Oncol Rep; 1998; 5(3):741-51. PubMed ID: 9538188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro transformation models: modeling human cancer.
    Heeg S; Doebele M; von Werder A; Opitz OG
    Cell Cycle; 2006 Mar; 5(6):630-4. PubMed ID: 16582608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetic aspects of neoplasms].
    Gar'kavtseva RF; Gar'kavtsev IV
    Vestn Ross Akad Med Nauk; 1999; (2):38-44. PubMed ID: 10204022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of oncogene/tumor suppressor networks during human carcinogenesis.
    Münger K
    Cancer Invest; 2002; 20(1):71-81. PubMed ID: 11853005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogene activation in rodent and human tumors.
    Anderson MW; You M; Reynolds SH
    Adv Exp Med Biol; 1991; 283():235-43. PubMed ID: 2068988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms, genomic imprinting and cancer susceptibility.
    Pulford DJ; Falls JG; Killian JK; Jirtle RL
    Mutat Res; 1999 Jan; 436(1):59-67. PubMed ID: 9878689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity: what is it good for?
    Ryland GL; Doyle MA; Goode D; Boyle SE; Choong DY; Rowley SM; Li J; ; Bowtell DD; Tothill RW; Campbell IG; Gorringe KL
    BMC Med Genomics; 2015 Aug; 8():45. PubMed ID: 26231170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
    Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
    J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic aspects of prostate cancer.
    Latil A; Lidereau R
    Virchows Arch; 1998 May; 432(5):389-406. PubMed ID: 9645438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of cancer predisposition and progression.
    Schwechheimer K; Cavenee WK
    Clin Investig; 1993 Jun; 71(6):488-502. PubMed ID: 8353410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview.
    Wang LH; Wu CF; Rajasekaran N; Shin YK
    Cell Physiol Biochem; 2018; 51(6):2647-2693. PubMed ID: 30562755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antioncogenes: models for tumors in children].
    Junien C; Henry I; Jeanpierre C; Lavedan C; Antignac C; Puech A; Beroud C
    Bull Cancer; 1991 Jan; 78(1):57-68. PubMed ID: 2021687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular oncogenes in neoplasia.
    Chan VT; McGee JO
    J Clin Pathol; 1987 Sep; 40(9):1055-63. PubMed ID: 3312299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome changes in human cancer--are they pointers to mechanisms of initiation?
    Tawn EJ
    Radiat Oncol Investig; 1997; 5(3):97-102. PubMed ID: 9303063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.